Samir Kaul, Director at Guardant Health, Inc. (GH), sold 8,000 shares at $156.95 ($1.3M) on 2021-04-05, disclosed to the SEC on 2021-04-07.
Open-market sale of $1.3M GH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.91 | 400 | $62K | 4.9% |
| 2 | $156.95 | 500 | $78K | 6.2% |
| 3 | $158.21 | 1,100 | $174K | 13.7% |
| 4 | $159.18 | 2,435 | $388K | 30.5% |
| 5 | $159.18 | 2,435 | $388K | 30.5% |
| 6 | $159.85 | 565 |
| $90K |
| 7.1% |
| 7 | $159.85 | 565 | $90K | 7.1% |
| Total | $158.84 avg | 8,000 | $1.3M | 100% |
| Filing → |
| GH | SELL | 2020-09-21 | $1.8M | — | Filing → |
| GH | SELL | 2020-08-19 | $1.7M | — | Filing → |
| GH | SELL | 2020-03-06 | $2.1M | — | Filing → |